Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

被引：0
|
作者：
Deborah JL Wong
Lidia Robert
Mohammad S Atefi
Amanda Lassen
Geetha Avarappatt
Michael Cerniglia
Earl Avramis
Jennifer Tsoi
David Foulad
Thomas G Graeber
Begonya Comin-Anduix
Ahmed Samatar
Roger S Lo
Antoni Ribas
机构：
[1] University of California Los Angeles (UCLA),Department of Medicine, Division of Hematology
[2] UCLA,Oncology
[3] UCLA,Department of Molecular and Medical Pharmacology
[4] Jonsson Comprehensive Cancer Center at UCLA,Department of Surgery, Division of Surgical
[5] Discovery Oncology Merck Research Laboratories,Oncology
[6] Merck Research Laboratories,Department of Medicine, Division of Dermatology
[7] UCLA,undefined
[8] University of Applied Sciences,undefined
[9] Universitat Autonoma de Barcelona,undefined
[10] UAB,undefined
来源：
Molecular Cancer | / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Chemotherapeutic drug selectivity between wild-type and mutant BRaf kinases in colon cancer
    Jianchun Zhang
    Tao Ji
    Journal of Molecular Modeling, 2017, 23
  • [32] Safety and efficacy of MET inhibitor tivantinib (ARQ 197) combined with sorafenib in patients (pts) with NRAS wild-type or mutant melanoma from a phase I study.
    Means-Powell, Julie Ann
    Adjei, Alex A.
    Puzanov, Igor
    Dy, Grace K.
    Goff, Laura Williams
    Ma, Wen Wee
    Fetterly, Gerald J.
    Michael, Shaunita A.
    Chai, Feng
    Lamar, Maria
    Schwartz, Brian E.
    Sosman, Jeffrey Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] Combined Inhibition of MEK and Plk1 Has Synergistic Antitumor Activity in NRAS Mutant Melanoma
    Posch, Christian
    Cholewa, Brian D.
    Vujic, Igor
    Sanlorenzo, Martina
    Ma, Jeffrey
    Kim, Sarasa T.
    Kleffel, Sonja
    Schatton, Tobias
    Rappersberger, Klemens
    Gutteridge, Rosie
    Ahmad, Nihal
    Ortiz-Urda, Susana
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (10) : 2475 - 2483
  • [34] Dinitroaniline Activity in Toxoplasma gondii Expressing Wild-Type or Mutant α-Tubulin
    Ma, Christopher
    Tran, Johnson
    Gu, Frank
    Ochoa, Roxanna
    Li, Catherine
    Sept, David
    Werbovetz, Karl
    Morrissette, Naomi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (04) : 1453 - 1460
  • [35] Wild-type enzyme as a reporter of inhibitor binding by catalytically impaired mutant enzymes
    Basarab, GS
    Jordan, DB
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 263 (03) : 617 - 620
  • [36] Efficacy and Safety of Nivolumab in Patients With BRAF V600 Mutant and BRAF Wild-Type Advanced Melanoma A Pooled Analysis of 4 Clinical Trials
    Larkin, James
    Lao, Christopher D.
    Urba, Walter J.
    McDermott, David F.
    Horak, Christine
    Jiang, Joel
    Wolchok, Jedd D.
    JAMA ONCOLOGY, 2015, 1 (04) : 433 - 440
  • [37] BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma
    Niessner, Heike
    Sinnberg, Tobias
    Kosnopfel, Corinna
    Smalley, Keiran S. M.
    Beck, Daniela
    Praetorius, Christian
    Mai, Marion
    Beissert, Stefan
    Kulms, Dagmar
    Schaller, Martin
    Garbe, Claus
    Flaherty, Keith T.
    Westphal, Dana
    Wanke, Ines
    Meier, Friedegund
    CLINICAL CANCER RESEARCH, 2017, 23 (20) : 6203 - 6214
  • [38] AKT is critically involved in the antagonism of BRAF inhibitor sorafenib against dabrafenib in colorectal cancer cells harboring both wild-type and mutant (V600E) BRAF genes
    Wang, Hongbin
    Quan, Haitian
    Lou, Liguang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 489 (01) : 14 - 20
  • [39] In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase
    Fogel, Gary B.
    Cheung, Mars
    Pittman, Eric
    Hecht, David
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2008, 26 (07): : 1145 - 1152
  • [40] Functional analysis of gene expression profiling of primary and metastatic melanoma: Possible implications from BRAF mutant and wild-type cell lines
    Essner, Richard
    Gong, Ke Wei
    Chmielowski, Bartosz
    Finn, Richard
    Tap, William D.
    Slamon, Dennis
    CANCER RESEARCH, 2012, 72
12345